Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
The Evolving State of Patient Centricity in the Pharmaceutical Industry
Patient centricity has been a point of discussion in pharma for years. Learn what patient...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs
As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...
Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy
Read this update on how the New England Journal of Medicine is trying to promote...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...